Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.
Access Medical Cannabis with T21
T21 is the largest observational medical cannabis study in the UK, gathering data on the efficacy of cannabis-based medicines for a wide range of conditions.
What is T21?
T21 allows eligible patients to access medical cannabis treatment at a discounted price, and have their treatment tracked by Drug Science.
Drug Science will use the data from T21 to provide evidence for NHS funding of medical cannabis treatment.
Receive monthly updates and the latest news on our data findings.
Watch our video on how T21 works
Why join T21?
You help us move closer to our ultimate goal of access to medical cannabis on the NHS by providing us with your data. We do this by asking patients to fill out a few questionnaires once every 3 months.
You’re in safe hands, with some of the UK’s leading medical cannabis clinicians prescribing at our participating clinics.
You can trust that your prescribed product will be high quality, as the study is supported by multiple industry partners offering EU GMP-certified products.
Drug Science is completely independent and observational, so there is no bias when it comes to which clinic you choose or what you will be prescribed.
We have worked with the licensed-producers to offer competitive prices on all T21 products.